William Blair Issues Positive Outlook for LRMR Earnings
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Analysts at William Blair raised their Q2 2025 earnings per share (EPS) estimates for shares of Larimar Therapeutics in a research note issued on Wednesday, April 30th. William Blair analyst M. Minter now expects that the company will post earnings per share of ($0.50) for the quarter, […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Analysts at William Blair raised their Q2 2025 earnings per share (EPS) estimates for shares of Larimar Therapeutics in a research note issued on Wednesday, April 30th. William Blair analyst M. Minter now expects that the company will post earnings per share of ($0.50) for the quarter, […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}